APA (7th ed.) Citation

XF, L., J, H., L, L., Y, T., JL, Z., YF, G., . . . F, G. (2025). Women with FSHR-inactivating mutations causing resistant ovarian syndrome benefit from oocyte in-vitro maturation. Reproductive biomedicine online, 50(6), 104733. https://doi.org/10.1016/j.rbmo.2024.104733

Chicago Style (17th ed.) Citation

XF, Li, et al. "Women with FSHR-inactivating Mutations Causing Resistant Ovarian Syndrome Benefit from Oocyte In-vitro Maturation." Reproductive Biomedicine Online 50, no. 6 (2025): 104733. https://doi.org/10.1016/j.rbmo.2024.104733.

MLA (9th ed.) Citation

XF, Li, et al. "Women with FSHR-inactivating Mutations Causing Resistant Ovarian Syndrome Benefit from Oocyte In-vitro Maturation." Reproductive Biomedicine Online, vol. 50, no. 6, 2025, p. 104733, https://doi.org/10.1016/j.rbmo.2024.104733.